FHL2 facilitates LUSC growth and therapy resistance through PI3K/AKT/mTOR activation
Abstract Four and a half LIM domain protein 2 (FHL2) plays a key role in tumorigenesis and progression. This study…
Abstract Four and a half LIM domain protein 2 (FHL2) plays a key role in tumorigenesis and progression. This study…
Abstract Background: Identification of patients at high risk of surgical-site infections may allow surgeons to minimize associated morbidity. However, there…